An insurer cannot pause its business to replace its software. Technumen works in that awkward gap, where better technology has to arrive while the old machinery keeps running.
An insurer can buy modern software and still spend its day moving information by hand. Exavalu has built a business around that awkward gap.
ValueMomentum spent 25 years learning the unglamorous machinery of property and casualty insurance. Its wager is that knowing where policies, claims and customer letters actually jam is more valuable than being the biggest consultant in the room.
Joseph D'Souza started with a chatbot for stranded policyholders. The more valuable business was hiding behind the call center: helping insurance employees find the one trustworthy answer buried across PDFs, portals, inboxes, and shared drives.
Angio8 (Shenzhen Tonglu Technology, 通甪科技) is a medical robotics company building a surgical robot and treatment platform for minimally invasive vascular interventional procedures. Its system lets physicians remotely manipulate catheters and guidewires with force feedback, aiming to make interventional surgery safer, more precise, and less reliant on repeated radiation exposure for the operating team. Founded in 2021 and based in Shenzhen's Bao'an District, the company is led by co-founder and CEO Yunfei (Richard) Cao and is backed by investors including Oriental Fortune Capital, Kangyu Capital and Ruiqian Capital.